Ciba-Geigy
E584144
Ciba-Geigy was a major Swiss pharmaceutical and chemical company that became one of the predecessors of Novartis after its merger with Sandoz in 1996.
All labels observed (5)
| Label | Occurrences |
|---|---|
| Ciba-Geigy canonical | 4 |
| J. R. Geigy AG | 4 |
| CIBA | 2 |
| Ciba Specialty Chemicals | 2 |
| Ciba | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T6311223 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Ciba-Geigy Context triple: [Novartis, foundedBy, Ciba-Geigy]
-
A.
Bayer
Bayer is a major German multinational pharmaceutical and life sciences company known for products such as aspirin and its work in healthcare and agriculture.
-
B.
Schering
Schering is a German surname most notably associated with Ernst Schering, a 19th-century pharmacist and founder of the pharmaceutical company Schering AG.
-
C.
Syntex
Syntex was a pioneering pharmaceutical company best known for its role in developing the first oral contraceptive pill and advancing steroid chemistry.
-
D.
Hoechst
Hoechst was a major German chemical and pharmaceutical company that later became part of the conglomerate IG Farben.
-
E.
SmithKline Beckman
SmithKline Beckman was a major American pharmaceutical and diagnostics company formed by the merger of SmithKline and Beckman Instruments, later becoming part of GlaxoSmithKline (GSK).
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Ciba-Geigy Target entity description: Ciba-Geigy was a major Swiss pharmaceutical and chemical company that became one of the predecessors of Novartis after its merger with Sandoz in 1996.
-
A.
Bayer
Bayer is a major German multinational pharmaceutical and life sciences company known for products such as aspirin and its work in healthcare and agriculture.
-
B.
Schering
Schering is a German surname most notably associated with Ernst Schering, a 19th-century pharmacist and founder of the pharmaceutical company Schering AG.
-
C.
Syntex
Syntex was a pioneering pharmaceutical company best known for its role in developing the first oral contraceptive pill and advancing steroid chemistry.
-
D.
Hoechst
Hoechst was a major German chemical and pharmaceutical company that later became part of the conglomerate IG Farben.
-
E.
SmithKline Beckman
SmithKline Beckman was a major American pharmaceutical and diagnostics company formed by the merger of SmithKline and Beckman Instruments, later becoming part of GlaxoSmithKline (GSK).
- F. None of above. chosen
Statements (46)
| Predicate | Object |
|---|---|
| instanceOf |
defunct company
ⓘ
pharmaceutical company ⓘ |
| country | Switzerland ⓘ |
| countryOfIncorporation | Switzerland ⓘ |
| dissolved | 1996 ⓘ |
| fate |
merged to form Novartis
ⓘ
linked to:
Novartis
|
| formedByMergerOf |
CIBA
ⓘ
linked to:
Ciba-Geigy
J. R. Geigy AG ⓘ
linked to:
Ciba-Geigy
|
| founded | 1970 ⓘ |
| hasLanguageOfWorkOrName |
English
ⓘ
French ⓘ German ⓘ |
| hasSuccessorOrganization |
Ciba Specialty Chemicals
ⓘ
linked to:
Ciba-Geigy
Novartis ⓘ |
| headquartersLocation |
Basel
ⓘ
linked to:
Basel-Stadt
|
| industry |
chemical industry
ⓘ
pharmaceutical industry ⓘ |
| locatedIn |
Basel
ⓘ
linked to:
Basel-Stadt
Canton of Basel-Stadt ⓘ Switzerland ⓘ |
| mergedWith | Sandoz ⓘ |
| mergerFormed | Novartis ⓘ |
| mergerYear | 1996 ⓘ |
| notableFieldOfResearch |
cardiovascular medicine
ⓘ
neuroscience ⓘ oncology ⓘ |
| notableFor |
being a predecessor of Novartis
ⓘ
large-scale pharmaceutical research ⓘ production of agrochemicals ⓘ production of dyes and pigments ⓘ |
| notableProduct |
clozapine
ⓘ
diclofenac ⓘ metoprolol ⓘ terbinafine ⓘ |
| operatedIn |
Asia
ⓘ
Europe ⓘ North America ⓘ |
| parentCompanyAfterMerger | Novartis ⓘ |
| predecessor |
CIBA
ⓘ
linked to:
Ciba-Geigy
J. R. Geigy AG ⓘ
linked to:
Ciba-Geigy
|
| sector |
life sciences
ⓘ
specialty chemicals ⓘ |
| stockExchangeListing | SIX Swiss Exchange ⓘ |
| successor |
Ciba Specialty Chemicals
ⓘ
linked to:
Ciba-Geigy
Novartis ⓘ |
| typeOfBusinessEntity | public company ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Ciba-Geigy Description of subject: Ciba-Geigy was a major Swiss pharmaceutical and chemical company that became one of the predecessors of Novartis after its merger with Sandoz in 1996.
Referenced by (13)
Full triples — surface form annotated when it differs from this entity's canonical label.
linked to: Ciba-Geigy
linked to: Ciba-Geigy
linked to: Ciba-Geigy
linked to: Ciba-Geigy
linked to: Ciba-Geigy
linked to: Ciba-Geigy
linked to: Ciba-Geigy
linked to: Ciba-Geigy
linked to: Ciba-Geigy